Coric Vlad
CIK 0001704317
Chief Executive OfficerDirector
Filings
20
Latest Mar 3, 2026
Issuers covered
5
Showing
20 of 20
Page 1
Track record
8 of 8 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 8 | 88% | +24.9% | +28.8% | +39.6% | -0.9% |
| 90 days | 8 | 75% | +73.5% | +56.1% | +195.4% | -22.2% |
| 180 days | 6 | 83% | +38.7% | +23.9% | +110.3% | -49.9% |
| 365 days | 4 | 50% | +20.5% | +26.2% | +97.2% | -67.7% |
Issuers
Companies where Coric Vlad has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| BHVN | Biohaven Ltd. | 12 | Mar 3, 2026 |
| RVNC | Revance Therapeutics, Inc. | 4 | Feb 6, 2025 |
| RPRX | Royalty Pharma PLC | 2 | May 14, 2025 |
| BHVN | Biohaven Pharmaceutical Holding Co Ltd. | 1 | Jan 7, 2022 |
| MANE | Veradermics, Inc | 1 | Feb 5, 2026 |
All filings
20 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|